MedTrace Logo

Analysis of Human Tear Proteins in Children

NCT00473278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2013-01-30

No results posted yet for this study

Summary

The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film, and any unique aspects of tears in children. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Conditions

  • Eye Disease

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Malik Y. Kahook, MD · Rocky Mountain Lions Eye Institute

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00473278 on ClinicalTrials.gov